Profile
Mr. Danny Margalit is Partner at Innodo Ventures.
Prior to Innodo, he was Ex-Aladdin Founder, Director & CTO.
Mr. Margalit received BA Computer Science, Tel Aviv University.
Danny Margalit active positions
Companies | Position | Start |
---|---|---|
AEYE Health LLC
AEYE Health LLC Packaged SoftwareTechnology Services AEYE Health LLC is a digital health company that provides fully autonomous, AI-based diagnostic screening solutions for retinal imaging with results. The company is based in New York, NY. The company aims to make diagnostic screening practical, accurate, and accessible. Its screening solution for diabetic retinopathy is FDA-cleared and designed to allow primary care providers to perform diabetic eye exams in their clinics instead of referring to specialists. AEYE Health enables point-of-care screening for diabetic retinopathy to ensure that patients with diabetes are regularly screened for diabetic retinopathy. The company's comprehensive screening utilizes AI technology to diagnose or predict the development of a broad range of diseases from retinal images. The team consists of machine learning experts and leaders in ophthalmology and innovation. The company was founded by Zack Dvey-Aharon, Danny Margalit. Zack Dvey-Aharon has been the CEO since incorporation. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
AEYE Health LLC
AEYE Health LLC Packaged SoftwareTechnology Services AEYE Health LLC is a digital health company that provides fully autonomous, AI-based diagnostic screening solutions for retinal imaging with results. The company is based in New York, NY. The company aims to make diagnostic screening practical, accurate, and accessible. Its screening solution for diabetic retinopathy is FDA-cleared and designed to allow primary care providers to perform diabetic eye exams in their clinics instead of referring to specialists. AEYE Health enables point-of-care screening for diabetic retinopathy to ensure that patients with diabetes are regularly screened for diabetic retinopathy. The company's comprehensive screening utilizes AI technology to diagnose or predict the development of a broad range of diseases from retinal images. The team consists of machine learning experts and leaders in ophthalmology and innovation. The company was founded by Zack Dvey-Aharon, Danny Margalit. Zack Dvey-Aharon has been the CEO since incorporation. | Technology Services |
- Stock Market
- Insiders
- Danny Margalit